Clinical Trial Update: Mecamylamine for Autonomic Dysreflexia Prophylaxis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating mec amylamine for prophylaxis of autonomic dysreflexia in spinal cord injury patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Mecamylamine (mecamylamine)

Snippet

Sponsor: Wayne State University | Conditions: Spinal Cord Injuries | Phase 4 | Status: UNKNOWN